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Abstract
Although phenylketonuria (PKU) is the most common genetic cause of mental retardation, the cellular
mechanisms underlying impaired brain function are still unclear. Using PAHenu2 mice (ENU2), the genetic
mouse model of PKU, we previously demonstrated that high phenylalanine levels interfere with brain
tryptophan hydroxylase activity by reducing the availability of serotonin (5-hydroxytryptamine, 5-HT),
crucial for maturation of neuronal connectivity in the prefrontal cortex (PFC), around the third postnatal
week, a critical period for cortical maturation. 5-Hydroxytryptophan (5-HTP), the product of tryptophan
hydroxylation, is known to be a better treatment to increase brain 5-HT levels. In this study we in-
vestigated the role of 5-HT during the early postnatal period in cognitive disturbances and in cortical
dendritic alterations of PKU subjects by restoring temporarily (postnatal days 14–21) physiological brain
levels of 5-HT in ENU2 through 5-HTP treatment. In adult ENU2 mice early 5-HTP treatment reverses
cognitive deﬁcits in spatial and object recognition tests accompanied by an increase in spine maturation of
pyramidal neurons in layer V of the prelimbic/infralimbic area of the PFC, although locomotor deﬁcits are
not recovered by treatment. Taken together, our results support the hypothesis that mental retardation in
PKU depends on reduced availability of brain 5-HT during critical developmental periods that interferes
with cortical maturation and point to 5-HTP supplementation as a highly promising additional tool to heal
PKU patients.
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Introduction
Phenylketonuria(PKU;McKusick2610600)isagenetic
disease that leads to severe mental retardation in
humans. PKU is caused by a deﬁciency of the phenyl-
alanine hydroxylase (PAH) enzyme, necessary to con-
vert phenylalanine (Phe) into tyrosine, resulting
in plasmatic hyperphenylalaninaemia (Scriver &
Waters, 1999) High levels of circulating Phe during
early postnatal development induce severe cognitive
and neurological disturbances. Thus, starting early
in life hyperphenylalaninaemic subjects are sub-
mitted to a Phe-restricted diet, which requires the ex-
clusion of several natural foods and supplementation
by unpleasant synthetic compounds to avoid nu-
tritional deﬁciencies. As compliance with dietary
treatment is diﬃcult, many PKU patients experience
neuropsychological consequences because their
hyperphenylalaninaemia is only partially controlled
(Giovannini et al. 2007; MacDonald, 2000). Moreover,
diet-compliant PKU patients also show some cognitive
and behavioural impairments (De Roche & Welsh,
2008; Diamond et al. 1997; Stemerdink, et al. 2000).
These facts indicate the urgent need to ﬁnd additional
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Altered Environmenttherapies in the treatment of hyperphenylalaninaemia
during development. Control of Phe accumulation by
sapropterin dihydrochloride (synthetic BH4) adminis-
tration and supplementation with large neutral amino
acids (LNAA; Phe, leucine, tyrosine, tryptophan, thre-
onine, isoleucine, valine, methionine, histidine) ap-
pears to be the only strategy for improving PKU
treatment because, currently, other therapeutic strat-
egies, such as gene therapy or treatment with Phe am-
monia-lyase (a non-mammalian enzyme that degrades
Phe), are currently unavailable (Burlina & Blau, 2009;
Lee et al. 2008; Sarkissian et al. 2009). Nevertheless,
the recent development of a genetic model of PKU has
raised hopes of developing treatments that go beyond
the simple reduction of blood Phe levels by targeting
the neuropathogenic eﬀects of hyperphenylalanin-
aemia. PAHenu2 mice (ENU2), created by chemically
induced genetic mutation (McDonald et al. 1990), are
characterized by a biochemical phenotype that closely
resembles untreated human PKU, as well as reduced
PAH enzyme activity, blood Phe levels 10–20 times
greater that those of normal littermates, PKU-typical
hypomyelination and behavioural deﬁcits (Cabib et al.
2003; Embury et al. 2005; Glushakov et al. 2005; Joseph
& Dyer, 2003; Martynyuk et al. 2005; Pascucci et al.
2002, 2008; Puglisi-Allegra et al. 2000; Smith & Kang,
2000; Zagreda et al. 1999).
Our studies on ENU2 mice have demonstrated
that excess Phe induces severe deﬁcits in brain sero-
tonin (5-hydroxytryptamine, 5-HT) availability by
directly interfering with tryptophan hydroxylase ac-
tivity and that these deﬁcits can be rescued in adult
hyperphenylalaninaemic mice by administering 5-
hydroxytryptophan (5-HTP), the immediate product
of tryptophan hydroxylase activity (Pascucci et al.
2002, 2008, 2009; Puglisi-Allegra et al. 2000). Phe-
induced interference with brain 5-HT metabolism
could play a crucial role in the abnormal neurode-
velopment associated with hyperphenylalaninaemia.
Indeed, 5-HT has been found to have regulatory
functions for brain development, and it has been im-
plicated in the formation and maintenance of dendritic
spines and in reﬁnement of synaptic connectivity
during postnatal development (Bennett-Clarke et al.
1994, 1995; Cases et al. 1996; Mazer et al. 1997; Okado
et al. 2001; Persico et al. 2001; Sodhi & Sanders-Bush,
2004; Whitaker-Azmitia, 2001). Indices of abnormal
synaptogenesis and dendritic development have been
found in most genetic syndromes characterized by
mental retardation, including PKU (Bauman &
Kemper, 1982; Huttenlocher, 1991, 2000; Kaufmann &
Moser, 2000; Kornguth et al. 1992). Moreover, cortical
synaptogenesis and dendritic development extend
well into postnatal life, particularly with regard to the
pyramidal neurons of the prefrontal cortex (PFC),
overlapping with the period of highest susceptibility
to Phe-induced developmental disturbances.
Finally, cortical development does not proceed lin-
early but through phases of over-production, pruning
and stabilization of connectivity, which are considered
the physiological mechanisms underlying the devel-
opmental brain plasticity and that are accompanied
by speciﬁc changes in brain amine availability. Thus,
‘peak’ increases in availability of brain amines marks
the critical developmental period (Goldman-Rakic &
Brown, 1982). In a recent study, we identiﬁed a peak
increase in brain 5-HT availability, the healthy genetic
background, around week 3 of postnatal life that
was markedly reduced and delayed in ENU2 mice
(Pascucci et al. 2008). This time window overlaps with
the critical period of synapse formation, dendritic
growth and remodelling, axonal reﬁnement and col-
umnarization in rodent cortices (Bennett-Clarke et al.
1994, 1995; Cases et al. 1996; Persico et al. 2001). Thus,
brain 5-HT deﬁcits observed during the critical post-
natal periodinENU2micecould beinvolvedinaltered
maturation of PFC and consequent cognitive deﬁcits.
Here we evaluated the eﬀects of 5-HTP adminis-
tration between postnatal days (PD) 14 and 21 on be-
havioural (motor and cognitive) and morphological
(dendritic morphology of pyramidal neurons in layer
V of prelimbic/infralimbic regions of PFC) proﬁles of
adult ENU2 mice.
Method
Animals and treatments
Homozygous (x/x) PahEnu2 (ENU2) and (+/+)
PahEnu2 (wild type; WT) male mice of BTBR back-
ground strain were issued from heterozygous mating.
Genetic characterization was performed on DNA
prepared from tail tissue using the Easy DNA kit
(Invitrogen, USA). The enu2 mutation was detected
after PCR ampliﬁcation of exon 7 of the Pah gene and
digestion with Alw261 restriction enzyme (Promega
Corporation, USA) as previously described (Pascucci
et al. 2008). Mice were aged 14 d at the beginning of the
treatment.
Three groups of ENU2 (ENU2, n=10; ENU2-Sal,
n=10; ENU2-5-HTP, n=10) and one group of healthy
genetic background (WT, n=10) mice were used for
behavioural and morphological analyses. Mice be-
longing to the ENU2-5-HTP group received injections
of 5-HTP (50 mg/kg) twice daily between PD 14 and
PD 21. The 5-HTP dose of 50 mg/kg was chosen
480 D. Andolina et al.because it was able to timely increase brain 5-HT
concentration of ENU2 to the same levels of age-
matched WT (Table 1). ENU2-Sal mice were subjected
to the same manipulations but were treated with
saline. At PD 28, animals were housed 2–4 per
standard breeding cage on a 12-h light/dark cycle
(lights on 07:00 hours) with food and water available
ad libitum. Behavioural experiments were performed
on adult mice (PD 60). At the completion of beha-
vioural experiments, all animals were anaesthetized
with chloral hydrate (400 mg/kg i.p.; Sigma, USA)
and perfused intracardially with saline. The brains
were dissected and processed for morphological
analyses.
Three additional groups of mice (WT, n=12; ENU2,
n=12; ENU2-5-HTP, n=12) were used to evaluate the
eﬀect of 5-HTP treatment on cerebral 5-HT levels at PD
14 (n=4 for group), PD 18 (n=4 for group) and PD 21
(n=4 for group).
All experiments were conducted in accordance
with European legislation (EEC no. 86/609), with
Italian national legislation (DL no. 116/92) governing
the use of animals for research, and with the guide-
lines of the National Institutes of Health on the use
and care of laboratory animals.
Behavioural analyses
All tests were conduced in a sound-attenuated cubicle,
and videotaped by means of a camera placed within
the cubicle and connected to a recorder placed outside
the cubicle. Video-based EthoVision System (Noldus,
The Netherlands) was used to record, collect and
analyse data of locomotor activity and object recog-
nition tests. Behaviours in the spatial novelty test were
recorded on computer keyboard by an experimenter
unaware of the experimental conditions and then
analysed by the Observer program (version 3.0,
System for Macintosh, Noldus).
Locomotor activity
Locomotor activity was measured in test cages made
of grey PVC (10r40r16 cm) and covered with trans-
parent Plexiglas. The acquired video tracks were pro-
cessed by the software to extract the variable ‘distance
moved’ (cm) and crossings as an estimate of loco-
motor activity. Behavioural recording sessions lasted
1 h. One-way ANOVAs were used for statistical
analysis of the eﬀects of group (four levels: WT,
ENU2, ENU2-Sal, ENU2-5-HTP) on 1 h-averaged dis-
tance moved and crossings. Time-dependent loco-
motor activity was analysed by repeated-measures
ANOVAs with one between factor (group, four levels:
WT, ENU2, ENU2-Sal, ENU2-5-HTP) and one within
factor (time, six levels: 10, 20, 30, 40, 50, 60 min),
followed by post-hoc planned comparisons, where
appropriate.
Object recognition test
The apparatus (Fig. 1b) and procedure have been
described previously (Cabib et al. 2003). The total time
spent exploring objects on pre-test session was ana-
lysed by one-way ANOVA with group as factor (four
levels: WT, ENU2, ENU2-Sal, ENU2-5-HTP), followed
by post-hoc Duncan’s test. Object recognition was
evaluated by comparison of novel vs. familiar object
exploration. The total time spent exploring each object
on the test session was evaluated by two-way ANOVA
for repeated measures (group, four levels: WT, ENU2,
ENU2-Sal and ENU2-5-HTP as between factor and
‘object’: two levels A3 and B, as within factor). Simple
eﬀect analysis of the factor ‘object’ was also evaluated
within each group.
Spatial novelty test
The apparatus (Fig. 1c) and procedure have been pre-
viously described (Cabib et al. 2003). The duration of
object exploration through sessions was measured and
used to evaluate the rate of habituation to experimen-
tal stimuli. Statistical analysis of these data was per-
formed by a two-way ANOVA for repeated measures
(group, four levels: WT, ENU2, ENU2-Sal, ENU2-5-
HTP as between factor; session, three levels: S2, S3, S4
as within factor) followed by post-hoc planned com-
parisons, where appropriate. A subsequent Duncan’s
test was performed on the overall means of the factor
session. Discrimination of spatial novelty was assessed
by evaluation of increased or decreased exploration of
Table 1. Brain levels of 5-HT (pg/mg wet weight) during
the third postnatal week
Postnatal
day
Group
WT ENU2 ENU2-5-HTP
PD 14 1780.3¡23.8 725.3¡21.9* 1100.0¡6.0*
PD 18 1591.4¡34.2 1004.8¡8.6* 1425.1¡74.4
PD 21 1556.0¡85.8 1267.4¡91.2* 1500.3¡102.2
Mean (¡S.E.M.) brain concentrations of 5-HT in WT, ENU2
and ENU2-5-HTP mice at diﬀerent postnatal days (PD 14,
PD 18, PD 21).
*p<0.01, vs. WT mice.
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Fig. 1 . 5-HTP administration between postnatal days 14 and 21 improves cognitive performances in adult ENU2 mice.
(a) Locomotor measures are shown as crossings (left panel) and distance moved (right panel). Insets show total responses
over 1-h test. (b) Results obtained in the object recognition test (left panel) expressed as time spent exploring the two identical
objects (A1, A2) during S2 pre-test session (middle panel) and as time spent exploring either the novel (B) or the familiar (A3)
object during S3 test session (right panel). 5-HTP early treatment restored object recognition ability in ENU2 mice. (c) Results
obtained in the spatial novelty test (right panel) expressed as mean time spent exploring all objects (A, B, C, D) during S2,
S3 and S4 (middle panel), and as changes in the time spent exploring the displaced object (DO; A, B) and the non-displaced
object (NDO; C, D) between the last habituation session (S4) and the test session (S5) (right panel). 5-HTP early treatment
also restored spatial novelty discrimination in ENU2 mice. All data are expressed as mean¡S.E.M.*p<0.05 vs. all other groups;
# p<0.05 vs. familiar object; · p<0.05 vs. NDO.
482 D. Andolina et al.two object categories: displaced object (DO) and non-
displaced objects (NDO). This measure was expressed
as the mean time in contact with DO or NDO in S5
minus the time spent in contact with the same object
category in S4. Statistical analysis of data was per-
formed by a two-way ANOVA for repeated measures
(group, four levels: WT, ENU2, ENU2-Sal, ENU2-5-
HTP as between factor; object category, two levels:
DO, NDO as within factor). Subsequent simple eﬀect
analysis of the factor ‘object category’ was performed
within each group.
After the mice were tested, they were sacriﬁced for
morphological analysis. Animals were anaesthetized
with chloral hydrate (400 mg/kg) and perfused
intracardially with 0.9% saline.
Morphological analyses
Golgi–Cox impregnation of brain tissue
Brains of mice of the diﬀerent groups (WT, n=10;
ENU2, n=10; ENU2-Sal, n=10; ENU2-5-HTP, n=10)
were impregnated with a standard Golgi–Cox solution
(1% potassium dichromate/1% mercuric chloride/
0.8% potassium chromate) according to a previously
described method (Glaser & Van der Loos, 1981). The
brains immersed in the Golgi–Cox solution were
stored at room temperature for 6 d and transferred to
a sucrose solution (30%) for 5 d. Coronal sections of
150 mM were obtained using a vibratome. Sections were
mounted on gelatinized slides, stained according to
the Gibb and Kolb method and covered with Eukitt
1
(Kindler GmbH & Co., Germany) (Gibb & Kolb, 1998).
Measurements were performed on impregnated
neurons (Fig. 2a) identiﬁed under low magniﬁcation
( r20/0.5 NA). Since no inter-hemispheric diﬀerences
were detected, three pyramidal cortex neurons with
the soma in layer V and apical dendrites reaching
layers II and IV were selected in the prelimbic and
infralimbic regions of the PFC of both hemispheres
(Bregma 1.98–1.78 mm) (Franklin & Paxinos, 1998).
For morphological anlysis, Golgi-impregnated neu-
rons were selected according to criteria proposed by
Vyas et al. (2002). An average of six neurons for each
mouse were analysed. A total of 240 neurons were
identiﬁed (WT, n=60; ENU2, n=60; ENU2-Sal,
n=60; ENU2-5-HTP, n=60) and included in statistical
analyses. An experimenter blind to the experimental
groups performed the morphological measurements.
Analysis of dendritic morphology
Morphological analysis of dendrites was performed
by measuring dendritic length and branching with a
light transmission microscope (Eclipse 80i, Nikon,
Japan) connected to a camera (DS5MC, Nikon) and
driven by software for quantitative analysis. The
length and the number of branch nodes of the den-
drites were quantiﬁed by tracing the apical shaft and
basal dendritic trees. On each dendrite category, den-
drite diameter was estimated under higher magniﬁ-
cation ( r100/0.75 NA). One-way ANOVAs were used
for statistical analysis of the eﬀects of group (four
levels: WT, ENU2, ENU2-Sal, ENU2-5-HTP) on apical
shaft length, total basal dendritic length and number
of total dendritic branches followed by post-hoc
Duncan’s test.
Analysis of spine morphology
Morphological analysis of spines was performed by
measuring spine density on all dendritic trees and
identifying the percentage of mature spines on apical
dendrite segments. Using the centre of soma as refer-
ence point, ﬁve 20-mM segments were sampled on api-
cal and basal dendrites, starting 50 mM distant from the
soma. The morphology of spines on apical dendrites
was performed under higher magniﬁcation ( r100/
0.75 NA). On each dendrite, all protrusions with a
clearlyrecognizableneckwereconsideredasspinesand
wereclassiﬁedaccording tothecategoriesproposedby
Peters & Kaiserman-Abramof (1969) as stubby, mush-
room and thin types, precluding discrimination of the
subtle variations in spine shape. Stubby spines pro-
trude from spiny dendrites with no neck visible: have
a length similar to the diameter of the neck and to the
head width; mushroom spines have a neck diameter
much smaller than the diameter of the head, head
width >2 neck width; thin spines have a head width
<2 neck width. The quantity of spines for each type in
each group is presented in Table 2. Spine types were
grouped as mature (stubby and mushroom) and im-
mature (thin) spines (Fig. 2b), and the level of spine
maturation is expressed as percentage of mature
spines on all counted spines. The reasons for using this
choice of classiﬁcation are based on literature describ-
ing diﬀerent physiological characteristics associated
with the diﬀerent shapes of spines (Chapleau et al.
2009; Harris, 1999; Knott et al. 2006; Marrs et al. 2001;
Matus, 2005; Nimchinsky et al. 2002; Peters &
Kaiserman-Abramof, 1969; Tyler & Pozzo, 2003; Ziv &
Smith, 1996). One-way ANOVAs were used for stat-
istical analysis of the eﬀect of group (four levels: WT,
ENU2, ENU2-Sal, ENU2-5-HTP) on apical and basal
dendritic spines (per 100 mm), mature and immature
apical dendritic spines and percentage of mature
spines (number of mature spines/number of counted
spinesr100), followed by post-hoc Duncan’s test.
Early serotonergic treatment in PKU 483Biochemical assay
Brain tissue was collected at PD 14, PD 18 and PD 21
(n=4 for each day) from WT, ENU2 and ENU2-5HTP
mice. For ENU2-5HTP mice, samples were collected
4 h after the second injection. All animals were killed
by decapitation and brains were removed and stored
in liquid nitrogen until the day of analysis. Tissue
levels of 5-HT were examined as reported previously
(Puglisi-Allegra et al. 2000). Data on 5-HT brain levels
were analysed by two-way ANOVAs for factors group
(three levels: WT, ENU2, ENU2-5-HTP); and post-
natal day (three levels: PD 14, PD 18, PD 21). In the
case of statistical signiﬁcance of both main eﬀects,
a simple eﬀect analysis of the factor group at each
time-point was performed.
Results
5-HTP administration between PD 14 and PD 21
improves cognitive performances in adult ENU2 mice
Deﬁcits in locomotor activity and mental retardation
are the main features of PKU. Since dramatic low
levels in brain 5-HT are the main biochemical deﬁcit in
ENU2 mice during the critical postnatal period, we
assessed the eﬀects of a pharmacologically induced
5-HT supply during the critical postnatal period
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Fig. 2. 5-HTP administration between postnatal days 14 and 21 increases the number of mature dendritic spines in frontal
cortical pyramidal neurons of adult ENU2 mice. (a) Schematic representation of prefrontal cortex (PFC), photomicrograph of
representative Golgi–Cox impregnated medium pyramidal neuron of layer V of the PFC and schematic depiction of the neuron
showing the position of apical shaft and basal and apical dendrites (left panel). There were no signiﬁcant diﬀerences between
groups in analysisof dendritic morphology: apical and basal dendritic length and basal branching (right panels). (b) High-power
photomicrographs of the representative apical dendritic segment and of categories of spines considered (mature: M=
mushroom; S=stubby; and immature: T=thin). Scale bar, 10 mm. ENU2 mice displayed signiﬁcantly more reduced basal
and apical dendrite density than all other groups. Although ENU2-Sal and ENU2-5-HTP mice displayed more basal and apical
spine density than ENU2 mice, only ENU2-5-HTP mice showed a recovery of spine maturation to WT levels. All data are
expressed as mean¡S.E.M.*p<0.05, ** p<0.001.
484 D. Andolina et al.(PD 14-21) on motor and cognitive deﬁcits in ENU2
adult mice.
To evaluate locomotor activity in ENU2 mice, we
used the locomotor activity test and measured cross-
ings and distance moved for 1 h. Compared to WT
mice, all other groups showed a dramatic and rapid
decrease in crossing and distance moved during the
1-h test. Statistical analysis of total outcomes over 1-h
test revealed a signiﬁcant eﬀect of group on total num-
ber of crossings (F3,36=13.73, p<0.001) and distance
moved (F3,36=29.86, p<0.0001). Statistical analysis of
time-dependent outcomes showed signiﬁcant groupr
time interactions for both crossings (F15,180=3.78,
p<0.001) and distance moved (F15,180=1.95, p<0.05).
These data display the inability of 5-HTP treatment to
recover locomotor deﬁcits in phenylketonuric mice.
To test cognitive performances we used two diﬀer-
ent non-associative tests, the object recognition test
and the spatial novelty test (Fig. 1b, c). These tests do
not require reinforcement and exploit rodents’ spon-
taneous preference for novelty. In particular, the object
recognition test is a variant for rodents of the delayed
non-matching to sample task whereas the spatial
novelty test measures the ability of rodents to encode
spatial relationships (Dix & Aggleton, 1999; Poucet,
1989; Roulle et al. 1997).
Statistical analysis of results obtained in the object
recognition test (Fig. 1b) revealed signiﬁcant interac-
tion between factors ‘object’ and group (F3,36=5.70,
p<0.01). Post-hoc analysis revealed signiﬁcant diﬀer-
ence in the time spent exploring the two objects (novel
vs. familiar) only in WT and ENU2-5-HTP mice that
spent more time in exploring the new object than the
familiar object.
Statistical analysis of results obtained in the spatial
novelty test (Fig. 1c) revealed signiﬁcant interaction
between object category and group (F3,36=3.84,
p<0.05). Post-hoc analysis revealed signiﬁcant diﬀer-
ence in the time spent exploring DO vs. NDO only in
WT and ENU2-5-HTP mice. No signiﬁcant diﬀerences
between groups were observed in the time spent ex-
ploring the two identical objects during the pre-test
session of the object recognition test, or in exploration
of objects during S2, S3 and S4 of the spatial novelty
test, suggesting that adult untreated ENU2 mice show
normal reactivity to stimuli presentation. However,
ENU2 mice do not display the typical spontaneous
preference of rodents for novel stimuli, showing
similar exploration between novel and familiar stim-
uli. These tests require coding and retrieving of infor-
mation based on visual and tactile perception and
represent good estimation of the rodent’s ability to
encode spatial and non-spatial information.
Results obtained in the object recognition and the
spatial novelty tests conﬁrm cognitive deﬁcits pre-
viously reported in adult ENU2 mice (Cabib et al.
2003) and demonstrate that the 5-HTP treatment is ef-
fective in preventing the development of either spatial
or non-spatial discrimination deﬁcits in ENU2 mice.
5-HTP administration between PD 14 and PD
21 increases the number of mature dendritic spines
in frontal cortical pyramidal neurons of adult
ENU2 mice
To determine dendritic process morphology, includ-
ing dendritic spine density and maturation, in ENU2
and WT mice, neurons impregnated with Golgi–Cox
Table 2. Density of total spines and of mushroom, stubby and thin spines
(number/100 mm)
Group
WT ENU2 ENU2-Sal ENU2-5-HTP
Total spines 48.30¡2.33 35.54¡1.13 47.36¡2.73 45.33¡2.85
Mushroom 27.87¡1.63 15.91¡0.69 20.15¡2.06 25.70¡2.08
(58.14%) (44.98%) (42.37%) (56.25%)
Stubby 6.04¡0.86 3.62¡0.33 4.49¡0.55 6.71¡0.54
(12.49%) (10.35%) (9.41%) (15.09%)
Thin 14.39¡1.47 16.01¡1.05 22.72¡1.99 12.92¡0.81
(29.37%) (44.66%) (48.28%) (28.66%)
Values are expressed as means¡S.E.M.
Total spine density and density of mushroom, stubby and thin spines on apical
dendrites of pyramidal neurons in layer V of prelimbic/infralimbic regions of PFC.
Values in parentheses are the percentage of each spine type.
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analyses revealed no signiﬁcant diﬀerences between
groups in: apical dendritic diameter (WT: 1.92¡
0.07 mm; ENU2: 1.77¡0.07 mm; ENU2-Sal: 2.02¡
0.10 mm; ENU2-5-HTP: 1.95¡0.08 mm), apical shaft
length (WT: 239.3¡5.99 mm; ENU2: 234.67¡6.81 mm;
ENU2-Sal: 254.28¡10.59 mm; ENU2-5-HTP: 254.40¡
8.94 mm) and basal dendritic length (WT: 88.09¡
3.98 mm; ENU2: 87.22¡4.30 mm; ENU2-Sal: 84.29¡
4.27 mm; ENU2-5-HTP: 88.22¡5.91 mm) and branch-
ing (WT: 3.51¡0.14; ENU2: 3.74¡0.25: ENU2-Sal:
3.67¡0.19; ENU2-5-HTP: 3.41¡0.11). Instead, signiﬁ-
cant diﬀerences between groups were revealed in
density of basal (F3,36=3.33, p<0.05) and apical (F3,36=
3.17, p<0.01) dendritic spines, number of mature
(F3,36=14.14, p<0.0001) and immature (F3,36=9.52,
p<0.0001) apical spines and in percentage of mature
spines (F3,36=19.38, p<0.0001). Post-hoc analyses re-
vealed that ENU2 mice showed reduction of basal and
apical spine density compared to all other groups and
lower levels of apical mature spines and reduced per-
centage of mature apical spines compared to WT and
ENU2-5-HTP mice (Fig. 2b). The ENU2-5-HTP group
showed a higher percentage of mature spines than
ENU2 and ENU2-Sal mice, reaching WT levels.
Finally, ENU2-Sal mice reported higher basal and
apical spine density and higher immature spines than
ENU2 mice, whereas no signiﬁcant diﬀerences ap-
peared between ENU2 and ENU2-Sal groups on total
and percentage of mature spines.
These results (Fig. 2b) are in agreement with human
data in indicating abnormal synaptogenesis in ENU2
mice. Moreover, they indicate that increase of brain
5-HT availability during postnatal development can
prevent at least part of the morphological deﬁcits
observable in the PFC of adult PKU-aﬀected mice.
Finally, observation of diﬀerences between ENU2 and
ENU2-Sal in basal and apical spine density is in
agreement with data showing that daily postnatal
handling alone alters spine density (Seib & Wellman,
2003).
Discussion
The major ﬁnding of the present study is that admin-
istering 5-HTP between PD 14 and PD 21 promotes
cognitive and morphological recovery in a mouse
model of untreated PKU. To our knowledge this is the
ﬁrst report of an eﬀective treatment of developmental
hyperphenylalaninaemia that does not target circulat-
ing Phe levels. Moreover, the present results oﬀer
strong support for the hypothesis that Phe interference
with brain 5-HT synthesis could be a major cause of
neurodevelopmental disturbances in hyperphenyl-
alaninaemic subjects, and suggest that the eﬃcacy of
Phe dietary restrictions might be improved by target-
ing the biochemical mechanisms of this interference.
Here, as previously reported, adult untreated ENU2
mice showed severe motor and cognitive disturb-
ances. The cognitive tasks used in this study provide
good estimation of rodents’ ability to encode spatial
and non-spatial information. Moreover, both tasks
involve PFC functioning and share common features,
i.e. they are non-associative, do not require exten-
sive training or manipulations of the emotional/
motivational state of the animals and are based on
rodents’ spontaneous preference for novelty (Akirav
& Maroun, 2006; Dix & Aggleton, 1999; Kessels et al.
2000; Poucet, 1989; Rinaldi et al. 2007; Roulle et al.
1997; Wallace et al. 2007). Although ENU2 mice are
interested in objects and show normal levels of object
exploration, they lack in increased exploration of the
novel or displaced object characteristics or location.
However, ENU2 mice are perfectly capable of re-
cognizing changes in the olfactory environment and of
increased exploration of an object if it can be identiﬁed
by a novel odour; thus, they show normal reactivity to
novelty per se (Cabib et al. 2003; Zagreda et al. 1999).
Taken together, the behavioural results are in agree-
ment with the proposal of a loss of behavioural ﬂexi-
bility in ENU2 mice recently advanced (Martynyuk
et al. 2010).
Morphological investigations of pyramidal neurons
in layer V of the prelimbic/infralimbic area of the
PFC showed that adult untreated ENU2 mice are
characterized by reduced densities of both basal and
apical dendritic spines and by a reduced percentage of
mature spines compared to healthy-background mice.
Although pathological alterations of axons, dendrites
and synapses in PKU brain have been reported pre-
viously, to our knowledge this is the ﬁrst demon-
stration of cortical morphological alterations in the
genetic murine model of PKU.
These results provide a quantitative measure of
the reduced connectivity in the PFC of ENU2 mice.
Normal cortical connectivity is an essential morpho-
logical characteristic for functioning of cortical areas,
and both behavioural tests used in this study require a
functioning PFC. Thus, it is reasonable to suppose
that the morphological alterations observed here
are responsible for cognitive deﬁcits shown by adult
PKU-aﬀected mice.
It is well known that 5-HT plays a crucial role in
regulating several relevant maturational events dur-
ing the ﬁrst three postnatal weeks (Bennett-Clarke et al.
1994, 1995; Cases et al. 1996; Goldman-Rakic & Brown,
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2001; Sodhi & Sanders-Bush, 2004; Whitaker-Azmitia,
2001). We recently observed low brain 5-HT levels in
ENU2 mice during PD 14-21, a time window of post-
natal development characterized by a peak of 5-HT
availability in healthy mice (Pascucci et al. 2008). Thus,
we hypothesized that low brain 5-HT levels during
this critical period could be the major cause of cogni-
tive and morphological abnormalities observed in
adult ENU2 mice. To assess this hypothesis, we
treated ENU2 pups during that postnatal phase with
the 5-HT direct precursor 5-HTP since this treatment is
capable of rescuing brain 5-HT transmission in adult
hyperphenylalaninaemic mice (Pascucci et al. 2009).
Adult ENU2 mice treated with 5-HTP between PD 14
and PD 21 were perfectly capable of spatial and object
discrimination as shown by their signiﬁcantly in-
creased exploration of novel or displaced objects.
Nonetheless, their motor deﬁcits were unaﬀected by
the treatment, as shown by the lack of diﬀerence in the
locomotion of treated and untreated ENU2 mice,
demonstrating a selective eﬀect of postnatal treatment
on PKU-associated cognitive deﬁcits.
The cognitive tests used in this study require a
functioning PFC (Akirav & Maroun, 2006; Kessels et al.
2000; Rinaldi et al. 2007; Wallace et al. 2007), although
involvement of other regions such as caudate nucleus
(White, 2009) and hippocampus (Martin & Clark,
2007; Winters et al. 2008) can not be ignored. Thus, it is
reasonable to hypothesize that the cognitive deﬁcits
observed in adult PKU-aﬀected mice depend on mor-
phological alterations in PFC neurons. Present data
improve information on anatomo-functional anom-
alies observed in ENU2 mice, as striatal/hippocampal
functioning alterations (Martynyuk et al. 2010).
Serotonin plays a crucial role in modulating the
neurodevelopment of cortical areas during the post-
natal period, including regulation of the spine mor-
phology of cortical pyramidal neurons. Therefore,
altered cortical functioning could be due to reduced
functional and morphological synaptic plasticity be-
cause of exposure to low levels of 5-HT during the
critical period of development.
The present results oﬀer strong support for the
hypothesis that Phe interference with brain 5-HT
synthesis could be a cause of neurodevelopmental
disturbances in hyperphenylalaninaemic subjects, and
suggest that the eﬃcacy of Phe dietary restrictions
might be improved by targeting the eﬀects of this
interference. In fact, adult PKU mice treated early with
5-HTP performed well on prefrontal cortical tests,
retrieving ability to encode spatial and non-spatial
information, and are characterized by dendritic
spine maturation in pyramidal neurons in layer V of
prelimbic/infralimbic regions of the PFC. In both
ENU2-Sal and ENU2-5-HTP groups spine density in
apical and basal dendrites was increased relative to
untreated ENU2 mice, conﬁrming that the stress of
daily injections alter dendritic spine density (Seib &
Wellman, 2003). Nevertheless, spine-density increase
in the ENU2-Sal group did not ﬁt together with the
enhancement of spine maturation, only observed in
ENU2-5-HTP mice.
Altogether, our data support the therapeutic use of
5-HTP as an alternative or a potential addition to a
Phe-free diet in PKU. 5-HTP is commercially available
and has been used clinically for a number of condi-
tions for over 30 yr. Furthermore, it can be easily ad-
ministered and is well tolerated (Turner et al. 2006).
In conclusion, the present data show that adult
phenylketonuric mice treated early with 5-HTP per-
formed well on prefrontal cortical tests, suggesting
that restoration of physiological 5-HT levels during
the critical postnatal period could become a new target
for PKU treatment.
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